From in vivo observations, a majority of M. tuberculosis cells in latently infected individuals are in a dormant and probably nonculturable state, display little metabolic activity, and are phenotypically resistant to antibiotics. Despite many attempts, no specific antimicrobials effective against latent tuberculosis have yet been found, partly because of a lack of reliable and adequate in vitro models for screening of drug candidates. We propose here a novel in vitro model of M. tuberculosis dormancy that meets the important criteria of latency, namely, nonculturability of cells, considerable reduction of metabolic activity, and significant phenotypic resistance to the first-line antibiotics rifampin and isoniazid. Using this model, we found a new group of 2-thiopyridine derivatives that had potent antibacterial activity against both actively growing and dormant M. tuberculosis cells. By means of the model of M. tuberculosis nonculturability, several new 2-thiopyridine derivatives were found to have potent antitubercular activity. The compounds are effective against both active and dormant M. tuberculosis cells. The bactericidal effects of compounds against dormant M. tuberculosis was confirmed by using three different in vitro models of tuberculosis dormancy. The model of nonculturability could be used as a reliable tool for screening drug candidates, and 2-thiopyridine derivatives may be regarded as prominent compounds for further development of new drugs for curing latent M. tuberculosis infection.
C
uring latent tuberculosis (TB) is a big challenge for modern chemotherapy (1) . One-third of the entire world population carries latent TB infection, with a lifelong risk of disease reactivation, which increases several times in immunocompromised patients (1, 2) . Mycobacterium tuberculosis cells associated with latent tuberculosis in the human host are believed to be in a special nonreplicating (dormant) state characterized by the development of considerable antibiotic tolerance (2) . This tolerance, described as phenotypic drug resistance, is due to changes in the physiological state of the bacteria, characterized by the low metabolic status of cells (2) .
Since specific and highly effective TB drugs for latency are still lacking, traditional antibiotics, such as isoniazid (INH) and rifampin (RIF), are used in current chemotherapy of latent TB. There are some therapeutic regimens based on long-term cure of latently infected patients with INH or RIF (3, 4) , although INH is weakly effective for latent TB infection because it targets the processes of bacterial cell wall biosynthesis (1) . The role of INH is probably to kill emerging bacilli that grow actively as a result of reactivation of dormant cells or conversion of slowly growing persisters into actively growing bacilli susceptible to INH treatment (5) . Significant tolerance of dormant cells for RIF was shown in the in vivo Cornell model of TB persistence (6) , calling into question the efficacy of RIF in curing latent TB. Moreover, it was postulated that dormant M. tuberculosis cells are phenotypically resistant to the sterilizing activity of RIF, and this feature is one of the hallmarks of dormant TB (7) .
Interestingly, in accordance with the Cornell model and some clinical studies, dormant cells in latently infected individuals are characterized by nonculturability, i.e., a phenomenon of transient inability to divide and grow on nonselective solid media (8) (9) (10) . A resuscitation procedure is required for such cells to enter an active growth state (8, 11) .
Consequently, there is a need for new drugs against latent TB infection. Since genome-derived, target-based approaches have had little success in the antibacterial therapeutic area in general (1), whole-bacterial-cell screening is believed to be a preferable approach for finding new drugs for TB, as it allows the testing of drug candidates in a relevant physiological state of the pathogen (1, 12) .
Several in vitro models of M. tuberculosis dormancy that were developed recently are currently being used to search for antilatency drugs (7, (13) (14) (15) ; however, dormant cells obtained in the vast majority of these in vitro models are fully culturable and metabolically active and are characterized by limited antibiotic resistance that may compromise their use in the search for drugs for latent TB.
We propose here a new in vitro model that mimics the phenomenon of TB latency. In this model, we managed to eliminate many of the limitations of the in vitro models mentioned above. In particular, dormant cells in this model are nonculturable (NC), have low metabolic activity, and are characterized by phenotypic resistance to both INH and RIF. Therefore, this in vitro model meets the key criteria of true dormancy and may be applied as a relevant tool for latent-TB drug discovery. Using this new model, we found a new group of 2-thiopyridine derivatives that had potent antibacterial activity against both actively growing and dormant M. tuberculosis cells.
MATERIALS AND METHODS
Chemistry. All reagents and solvents were purchased from commercial suppliers and used without further purification. Melting points were determined on an Electrothermal 9001 and are uncorrected. 1 Bacterium and media. M. tuberculosis strain H37Rv was grown from frozen stocks for 10 to 12 days in Sauton medium containing 0.5 g KH 2 PO 4 , 1.4 g MgSO 4 · 7H 2 O, 4 g L-asparagine, 60 ml glycerol, 0.05 g ferric ammonium citrate, 2 g sodium citrate, 0.1 ml 1% ZnSO 4 · 7H 2 O, H 2 O to l liter, pH 7.0 (adjusted with 1 M NaOH) (16) and supplemented with ADC (albumin, glucose, and NaCl) and 0.05% Tween 80 (37°C; 200 rpm).
Dormant-cell preparation. To obtain nonculturable (dormant) cells, a culture grown in Sauton medium to an optical density at 600 nm (OD 600 ) of 5 served as an inoculum that was added to potassium-deficient Sauton medium supplemented with ADC and 0.05% Tween 80 (37°C; 200 rpm) at a concentration of 5 ϫ 10 5 cells per ml. Potassium-deficient Sauton medium contains 8.9 g Na 2 HPO 4 · 12H 2 O, 1.4 g MgSO 4 · 7H 2 O, 4 g L-asparagine; 60 ml glycerol, 0.05 g ferric ammonium citrate, 2 g sodium citrate, 0.1 ml 1% ZnSO 4 · 7H 2 O, H 2 O to l liter, pH 7.0 (adjusted with 1 M NaOH).
To obtain dormant M. tuberculosis cells in the Wayne hypoxia model and Betts starvation model, the appropriate conditions were applied (13, 14) . Briefly, for the Wayne dormancy model, M. tuberculosis was grown in Dubos medium (HiMedia; India) at 37°C in sealed tubes. The cells ceased replicating after 7 to 8 days, when the oxygen concentrations decreased to the microaerobic level (1% oxygen saturation), and entered a nonreplicating persistence state. With continued incubation, the oxygen tension decreased to the anaerobic level (0.06% oxygen saturation), and the anaerobic culture was harvested at 14 days. For the Betts starvation model, cultures grown for 7 days in nutrient-rich medium were pelleted, washed twice with phosphate-buffered saline (PBS), and then resuspended in PBS and left standing at 37°C in sealed bottles for 6 weeks.
Resuscitation of nonculturable cells. The resuscitation procedure was performed in diluted liquid Sauton medium (1:1 [vol/vol]; final concentration of glycerol, 0.6%) supplemented with ADC. Nonculturable cells obtained in potassium-deficient Sauton medium were harvested, washed twice with fresh medium, resuspended in ADC-supplemented diluted Sauton medium, and left standing at 37°C. The number of resuscitated cells was estimated by most probable number (MPN) assay (17) .
Viability estimation. For CFU counting, 10-fold dilutions of M. tuberculosis suspensions were plated in triplicate on agar-solidified ADCsupplemented Sauton medium (limit of detection, 5 CFU per ml). The plates were incubated at 37°C for 21 to 25 days. For the MPN assay (17), 10-fold bacterial dilutions were resuspended in ADC-supplemented diluted liquid Sauton medium in 48-well Corning microplates. The microplates were incubated at 37°C for 30 days without agitation. Wells with visible bacterial growth were counted as positive, and MPN values were calculated using standard statistical methods (17) .
Incorporation of radioactive uracil. Culture samples (1 ml) were placed in 2-ml screw cap tubes with 5,6-3 H uracil (1 Ci) and incubated at 37°C with agitation for 20 h. Then, 0.2 ml of the culture was placed in a 15-ml Falcon tube with 3 ml of 10% ice-cold CCl 3 COOH and incubated on ice for 15 min. The mixture was then filtered through a Whatman glass microfiber filter (GFC) and washed with 3 ml 7% CCl 3 COOH and 6 ml 96% ethanol. The filters were then placed in 10 ml of scintillation mixture, and counts were determined using an LS analyzer (Beckman Instruments, Inc.).
MIC determination. The MIC for M. tuberculosis H37Rv was determined according to the CLSI guidelines (18) using a broth microdilution method in Middlebrook 7H9 medium supplemented with ADC, with a final inoculum of 5 ϫ 10 5 cells/ml. The compounds were dissolved in DMSO (1 mg/ml) and used as a stock solution. Concentrations ranging from 31.25 to 4,000 ng/ml (at these concentrations, the compounds were soluble in the medium) were used to assess the effectiveness of the compounds. Microtiter plates were incubated at 37°C for 72 h, and the MIC value represents the lowest dilution of the compound at which no bacterial growth was detected.
Estimation of bactericidal effect. Both log-phase and dormant cells were exposed to different concentrations of RIF, INH, and 2-thiopyridines for 7 days (37°C; 200 rpm). Both treated and untreated 10-folddiluted suspensions were employed in triplicate for MPN assays in ADCsupplemented diluted liquid Sauton medium in 48-well Corning microplates at 37°C for 30 days without agitation. MPN values were calculated using standard statistical methods (17) .
RESULTS AND DISCUSSION
Model of M. tuberculosis nonculturability. As previously demonstrated, potassium deficiency led to the development of nonculturability in Mycobacterium smegmatis cells (19) . The application of a similar approach induced nonculturability in M. tuberculosis bacilli: the cultivation of cells under potassium-deficient conditions led to their transition to a reversible NC state after a 30-day incubation period (Fig. 1) . More than 99% of M. tuberculosis cells were unable to form colonies on standard solid medium after a 30-day incubation period under potassium-limiting conditions, but the NC cells remained viable and could be resus- The main problem for all in vitro dormancy models is the presence of cells with different physiological status in the population (11) . Therefore, elimination of replicating/active cells is a crucial point for establishing a model with a high proportion of truly dormant cells. In particular, penicillin treatment was used for enrichment of dormant Micrococcus luteus cells (20) , and Hu and colleagues have suggested applying RIF to kill viable cells in the population of long-stationary-phase M. tuberculosis cells (21) . As a result, they obtained a population of persistent M. tuberculosis cells; however, the concentration was very low (ca. 10 2 cells/ml). In order to obtain a population enriched with dormant NC cells and to remove metabolically active cells, a 15-day-starved M. tuberculosis culture was additionally incubated in the presence of a moderate concentration of RIF (5 g/ml), which should not affect the viability of dormant cells (7) . After such additional treatment of a 15-day-starved culture with RIF for 10 to 12 days, a "zero-CFU" population of NC cells was obtained. These cells were unable to produce colonies on solid medium but were still characterized by a high recovery potential estimated by MPN assay: when cultivated in diluted Sauton medium, 1 ϫ 10 8 cells/ml (close to the MPN for starved cells without rifampin) were able to resuscitate and transition into a fully culturable state (Fig. 1) . This high recovery potential of the zero-CFU population was maintained for at least 10 to 14 days after M. tuberculosis cells entered a zero-CFU state.
Despite the ability to recover from the NC state, the metabolic activity of cells in the zero-CFU population was very low, according to the rate of radioactive uracil incorporation, correlating with transcriptional activity of the cells. While viable log-phase M. tuberculosis cells demonstrated a rate of radioactivity incorporation of approximately 40,000 cpm, estimated for 1 ϫ 10 7 cells, this parameter was at least 100-fold less for the same number of NC cells. This was in contrast to the metabolic activity of persisters obtained after exposure to a high concentration of RIF (100 g/ ml), which was just 4 times less than the parameter in log-phase cells (21) , which means that Hu et al.'s persisters did not demonstrate a dramatic metabolic reduction. This discrepancy could be explained by the different physiological states of the cells in these two models.
Apart from reduced metabolic activity, NC cells were morphologically distinct from actively growing cells (they were sphere shaped) and were characterized by considerable resistance to anti-TB drugs. Namely, treatment of NC cells in the zero-CFU population with two first-line anti-TB drugs, RIF and INH (both at 5 g/ml), resulted in no effect on their ability to recover from the NC state in diluted liquid Sauton medium (Fig. 2) . Poor killing effect was demonstrated even after treating the cells with 10-foldhigher doses (Fig. 2) . The sensitivity to RIF and INH of cells obtained after resuscitation and the suppression of resuscitation from the NC state in the presence of 5 g/ml RIF and INH (not shown) showed that the antibiotic resistance that developed in NC cells is phenotypic.
We compared the sensitivities to antibiotics of cells obtained in different in vitro dormancy models with that of the cells produced in the model described in this study ( Table 1 ). Given that the population of dormant cells possibly contains a fraction of NC cells and that it is impossible to reveal the susceptibility of NC cells to drugs by plating, we applied cell counting in a liquid medium (MPN assay), along with standard CFU counting, to estimate the killing effects of antibiotics. Cells in all dormancy models were expected to be characterized by their considerable resistance to INH (7, (13) (14) (15) , because the drug impacts the biosynthesis of cell wall mycolic acids, a process that is evidently inactive in dormant and even in aged cells. However, dormant cells in all previously published M. tuberculosis dormancy models demonstrated significant susceptibility to RIF, which in turn may indicate some tran- scriptional activity in such cells. Resistant dormant NC cells in this study are evidently characterized by deeper dormancy (11) than in previously published models. Similarly, deep persistence was reported to be characterized by very low metabolic activity and the ability to survive under longer antibiotic exposure and high concentrations (22) .
2-Thiopyridine derivatives are effective against both active and dormant M. tuberculosis cells. Earlier, some 2-thiopyridine derivatives were found to have antileprosy activity (23) . We therefore proposed that this group of chemical compounds may also possess anti-TB activity. In the present study, we removed the potentially toxic nitro group and introduced a thiocyanato group as a result of different chemical modifications of the basic structures of 2-thiopyridine, together with structure-activity relationship (SAR) studies. During SAR research, we also suggested that one of the key factors of the antimicrobial activity of this group in the compounds is the level of positive charge on the second carbon atom of the pyridine ring. To confirm this hypothesis, we synthesized several compounds in which the pyridine nitrogen atom was oxidized. Then, the anti-TB activities of five 2-thiopyridine derivatives were studied (Fig. 3) . Two compounds from this series, namely, 11026103 and 11026115, demonstrated MICs of 0.25 g/ml ( Table 2 ).
The effectiveness of these five compounds was checked in the model of nonculturability of M. tuberculosis cells. As these NC cells are unable to produce colonies on nonselective agar-solidified media, we applied the MPN assay to check the effects of these compounds on the viability of dormant NC cells. In contrast to CFU counting, this approach is able to uncover a subpopulation of cells with decreased culturability that may arise as a result of antibiotic treatment.
It was found that incubation of NC M. tuberculosis cells with some of the above-mentioned compounds affected their viability. In particular, incubation of NC cells with 10 g/ml of both 11026114 and 11026115 for 7 days led to a more than 2-log-unit killing effect (Fig. 4) . At the same time, NC cells are highly resistant to RIF and INH, even at a high concentration (50 g/ml) (Fig.  2) . The susceptibility of NC cells to the 2-thiopyridine derivatives may indicate the existence of some residual metabolic activity in the latent state of the pathogen, which may be potentially targeted by novel antimicrobials. While the target(s) of studied compounds in M. tuberculosis is not clear, some thiopyridines were identified as inhibitors of M. tuberculosis alanine racemase, which plays an essential role in cell wall synthesis (24) , or enoyl-acyl carrier protein reductase, which catalyzes an essential step in fatty acid biosynthesis (25) . However, the MIC for M. tuberculosis reported for the first inhibitor is 50 times higher than for the compounds described in the present study, and the second inhibitor was not tested on mycobacteria. Thus, the mechanism of action of the compounds discovered in the present work remains to be elucidated. To further study the effectiveness of 2-thiopyridine derivatives against dormant M. tuberculosis cells, we selected the compound 11026115 and performed two other well-known in vitro dormancy models: the Wayne hypoxia model (13) and the Betts starvation model (14) . Dormant cells obtained in different models were treated with 10 g/ml 11026115 for 7 days. As the population of dormant cells in these models may contain a fraction of NC cells (arising before or after treatment), we applied the MPN assay for estimation of the killing effect of 11026115 instead of a standard CFU count. According to the MPN assay, dormant cells in these models are characterized by slightly higher resistance to both RIF and INH than was reported previously (7, (13) (14) (15) . Probably, antibiotic treatment induces the partial transition of cells to an NC state instead of cell death, which was not noticed earlier because standard CFU counting was applied. We also observed a significant killing effect of compound 11026115 on these dormant M. tuberculosis cells obtained in the Wayne hypoxia model and the Betts starvation model in vitro (Fig. 5) . Despite the fact that dormant cells in both models are rather susceptible to RIF, treatment with compound 11026115 demonstrated an even stronger effect than treatment with RIF in all three M. tuberculosis in vitro dormancy models, and its effectiveness on actively growing cells was comparable to those of both RIF and INH. Thus, we may conclude that several 2-thiopyridines are able to kill dormant M. tuberculosis bacteria.
Despite the recent success with drug candidates such as diarylquinolines (TMC207), which target ATP synthesis (26, 27) , and benzothiazinones (BTZ043), which target essential cell wall arabinan synthesis (28) , the efficacies of both candidates at killing dormant bacilli were found to be low. For example, BTZ043 failed to kill cells with low metabolic status (15, 28, 29) , and the specific TMC207 affected the viability of dormant cells in the Wayne model but not the viability of nutrient-starved organisms (30) .
By a combination of two approaches-potassium deficiency and RIF treatment-we obtained a population containing dormant NC cells at a high concentration. The in vitro model proposed in this study produces dormant NC cells that are characterized by remarkable metabolic cessation and considerable phenotypic resistance to both RIF and INH. Therefore, this model meets the key criteria for latent TB and may be applied as a relevant tool for latent-TB drug discovery. Here, we demonstrated for the first time that 2-thiopyridines are able to kill dormant M. tuberculosis cells obtained under three different types of stress: hypoxia, nutrient starvation, and nonculturability under potassium limitation. The most active compound was 11026115, which kills dormant M. tuberculosis bacteria obtained in all three in vitro models of dormancy. We suggest 2-thiopyridine derivatives as a prominent group of compounds for further development of drugs for curing latent TB. 
